19212931

Source:http://linkedlifedata.com/resource/pubmed/id/19212931

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006405, umls-concept:C0240293, umls-concept:C0301630, umls-concept:C1169989, umls-concept:C1533685, umls-concept:C1875307
pubmed:issue	2
pubmed:dateCreated	2009-3-26
pubmed:abstractText	Diversion of buprenorphine (BPN) has been described in settings where it is legally prescribed and has resulted in increasing concern. To address this concern, co-formulation of buprenorphine/naloxone (BPN/NLX) replaced buprenorphine alone in Malaysia in December 2006.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/K23 DA022143, http://linkedlifedata.com/resource/pubmed/grant/K24 DA017072, http://linkedlifedata.com/resource/pubmed/grant/K24 DA017072-04, http://linkedlifedata.com/resource/pubmed/grant/K24 DA017072-09
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19212931-11064186, http://linkedlifedata.com/resource/pubmed/commentcorrection/19212931-11182872, http://linkedlifedata.com/resource/pubmed/commentcorrection/19212931-11303059, http://linkedlifedata.com/resource/pubmed/commentcorrection/19212931-12665117, http://linkedlifedata.com/resource/pubmed/commentcorrection/19212931-12925043, http://linkedlifedata.com/resource/pubmed/commentcorrection/19212931-1414399, http://linkedlifedata.com/resource/pubmed/commentcorrection/19212931-15029983, http://linkedlifedata.com/resource/pubmed/commentcorrection/19212931-15204673, http://linkedlifedata.com/resource/pubmed/commentcorrection/19212931-15679749, http://linkedlifedata.com/resource/pubmed/commentcorrection/19212931-16284682, http://linkedlifedata.com/resource/pubmed/commentcorrection/19212931-16902719, http://linkedlifedata.com/resource/pubmed/commentcorrection/19212931-16902726, http://linkedlifedata.com/resource/pubmed/commentcorrection/19212931-16902730, http://linkedlifedata.com/resource/pubmed/commentcorrection/19212931-17075655, http://linkedlifedata.com/resource/pubmed/commentcorrection/19212931-17075657, http://linkedlifedata.com/resource/pubmed/commentcorrection/19212931-17109309, http://linkedlifedata.com/resource/pubmed/commentcorrection/19212931-17502234, http://linkedlifedata.com/resource/pubmed/commentcorrection/19212931-17538746, http://linkedlifedata.com/resource/pubmed/commentcorrection/19212931-17925988, http://linkedlifedata.com/resource/pubmed/commentcorrection/19212931-18584580, http://linkedlifedata.com/resource/pubmed/commentcorrection/19212931-6281389, http://linkedlifedata.com/resource/pubmed/commentcorrection/19212931-8173501, http://linkedlifedata.com/resource/pubmed/commentcorrection/19212931-8370341, http://linkedlifedata.com/resource/pubmed/commentcorrection/19212931-9048270
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7502510
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Buprenorphine, http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations, http://linkedlifedata.com/resource/pubmed/chemical/Naloxone, http://linkedlifedata.com/resource/pubmed/chemical/Narcotic Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/suboxone
pubmed:status	MEDLINE
pubmed:issn	1097-9891
pubmed:author	pubmed-author:AlticeFrederick LFL, pubmed-author:BruceR DouglasRD, pubmed-author:GovindasamySumathiS, pubmed-author:KamarulzamanAdeebaA, pubmed-author:SyllaLaurieL
pubmed:issnType	Electronic
pubmed:volume	35
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	68-72
pubmed:dateRevised	2011-8-1
pubmed:meshHeading	pubmed-meshheading:19212931-Adult, pubmed-meshheading:19212931-Buprenorphine, pubmed-meshheading:19212931-Drug Combinations, pubmed-meshheading:19212931-Humans, pubmed-meshheading:19212931-Logistic Models, pubmed-meshheading:19212931-Malaysia, pubmed-meshheading:19212931-Male, pubmed-meshheading:19212931-Middle Aged, pubmed-meshheading:19212931-Naloxone, pubmed-meshheading:19212931-Narcotic Antagonists, pubmed-meshheading:19212931-Needle Sharing, pubmed-meshheading:19212931-Opioid-Related Disorders, pubmed-meshheading:19212931-Risk-Taking, pubmed-meshheading:19212931-Substance Abuse, Intravenous, pubmed-meshheading:19212931-Substance Withdrawal Syndrome, pubmed-meshheading:19212931-Young Adult
pubmed:year	2009
pubmed:articleTitle	Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market.
pubmed:affiliation	Yale University AIDS Program, New Haven, Connecticut, USA. Robert.bruce@yale.edu
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural